London – As a clinician who’s worked with thousands of patients, urologic oncologist Sumeet Bhanvadia, M.D., Senior Director, the Janssen Pharmaceutical Companies of Johnson & Johnson, has seen firsthand how difficult and burdensome a bladder cancer diagnosis can be. Bladder cancer patients tend to be older—in the U.S., the median age of diagnosis is 72—and already balancing an array of …
London – Application is supported by data from the Phase 3 CARTITUDE-4 study, which showed significant improvement in primary endpoint of progression-free survival (PFS) CARTITUDE-4 is the first randomized Phase 3 study investigating the efficacy of a cell therapy as early as after first relapse in multiple myeloma RARITAN, N.J., June 6, 2023 – The Janssen Pharmaceutical Companies of Johnson …
